Tidal Investments LLC Has $12.76 Million Position in Chemed Co. (NYSE:CHE)

Tidal Investments LLC boosted its position in Chemed Co. (NYSE:CHE - Free Report) by 1,315.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 24,085 shares of the company's stock after acquiring an additional 22,383 shares during the period. Tidal Investments LLC owned 0.16% of Chemed worth $12,760,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CHE. Neuberger Berman Group LLC boosted its holdings in Chemed by 1.2% during the fourth quarter. Neuberger Berman Group LLC now owns 501,562 shares of the company's stock worth $265,726,000 after buying an additional 5,809 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Chemed by 1.5% during the fourth quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock worth $180,654,000 after buying an additional 4,966 shares during the last quarter. FMR LLC boosted its holdings in Chemed by 18.9% during the fourth quarter. FMR LLC now owns 283,790 shares of the company's stock worth $150,352,000 after buying an additional 45,174 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Chemed by 8.2% during the fourth quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company's stock worth $141,343,000 after buying an additional 20,310 shares during the last quarter. Finally, Epoch Investment Partners Inc. boosted its holdings in Chemed by 5.1% during the fourth quarter. Epoch Investment Partners Inc. now owns 252,237 shares of the company's stock worth $133,635,000 after buying an additional 12,167 shares during the last quarter. Institutional investors own 95.85% of the company's stock.

Insider Transactions at Chemed

In other Chemed news, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total transaction of $866,790.00. Following the completion of the transaction, the executive vice president now owns 16,127 shares of the company's stock, valued at $9,319,148.22. This represents a 8.51% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares of the company's stock, valued at approximately $62,566,139.07. This trade represents a 0.97% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,500 shares of company stock valued at $4,401,120 over the last 90 days. 3.29% of the stock is owned by company insiders.

Chemed Trading Up 1.3%

Shares of NYSE CHE traded up $7.54 during mid-day trading on Friday, reaching $568.98. 113,071 shares of the company's stock were exchanged, compared to its average volume of 103,064. The firm has a market capitalization of $8.32 billion, a price-to-earnings ratio of 28.75, a PEG ratio of 2.15 and a beta of 0.59. The business has a fifty day simple moving average of $583.60 and a 200 day simple moving average of $565.45. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. The company had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. Chemed's revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the firm posted $5.20 earnings per share. Equities research analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date is Thursday, May 29th. Chemed's dividend payout ratio is currently 9.74%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on CHE shares. Royal Bank of Canada raised their target price on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a report on Monday, April 28th. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.